## 3 Results
### Test-Retest Reliability
\begin{table}
\begin{tabular}{l l l l l l l l l l} \hline \hline \multicolumn{1}{c}{**Implanted Ears with SNHL**} & \multicolumn{6}{c}{**Non-Implanted Ears with SNHL**} \\ \hline \multirow{2}{*}{**Ear \# (Patient \#)**} & \multirow{2}{*}{\begin{tabular}{c} **ECV** \\ **mL** \\ \end{tabular} } & \multirow{2}{*}{\begin{tabular}{c} **TPP** \\ **daPa** \\ \end{tabular} } & \multirow{2}{*}{\begin{tabular}{c} **SC** \\ **(mL)** \\ \end{tabular} } & \multirow{2}{*}{**Type**} & \multirow{2}{*}{**Ear \# (Patient \#)**} & \multirow{2}{*}{\begin{tabular}{c} **ECV** \\ **mL** \\ \end{tabular} } & \multirow{2}{*}{\
\begin{tabular}{c} **TPP** \\ **daPa** \\ \end{tabular} } & \multirow{2}{*}{
\begin{tabular}{c} **SC** \\ **(mL)** \\ \end{tabular} } & \multirow{2}{*}{**Type**} \\ \hline
1 (1) & 1.19 & \(-\)10 & 0.51 & A & 1 (1) & 0.85 & \(-\)12 & 0.44 & A \\ \hline
2 (2) & 0.55 & \(-\)23 & 0.45 & A & 2 (2) & 0.72 & \(-\)2 & 0.49 & A \\ \hline
3 (3) & 1.06 & \(-\)10 & 0.67 & A & 3 (3) & 1.02 & \(-\)4 & 0.98 & A \\ \hline
4 (4) & 0.86 & \(-\)4 & 0.37 & A & 4 (4) & 1.25 & 6 & 0.87 & A \\ \hline
5 (5) & 0.96 & \(-\)10 & 0.39 & A & 5 (5) & 0.96 & 2 & 0.4 & A \\ \hline
6 (6) & 0.55 & \(-\)7 & 0.47 & A & 6 (6) & 0.52 & 0 & 0.68 & A \\ \hline
7 (7) & 1.23 & 15 & 0.51 & A & 7 (7) & 0.93 & \(-\)6 & 0.54 & A \\ \hline
8 (8) & 0.84 & \(-\)64 & 0.74 & C & 8 (8) & 0.66 & \(-\)97 & 0.95 & C \\ \hline
9 (9) & 1.03 & \(-\)9 & 1.1 & A & 9 (10) & 0.89 & \(-\)43 & 0.77 & A \\ \hline \hline \end{tabular}
\end{table} 
Table 2: Tympanometry values for the implanted and non-implanted ears. Figure 3: Absorbance per frequency compared between right and left ears in normal-hearing persons, averaged over the pressure settings. No statistically significant difference was associated with laterality. The bars reflect the 95% confidence intervals. ANOVA was conducted to explore differences in absorbance between the three groups in this study. In this analysis, data were compared between implanted and hearing-impaired non-implanted ears (of the same person in unilaterally implanted participants, n = 15) using a mixed-model ANOVA (MANOVA) for the WBT tab (ambient, peak). In this model, frequency (16 levels) and pressure (ambient vs. peak-2 levels) served as within \begin{table}
\begin{tabular}{l l l l l l l l l} \hline \hline \multicolumn{1}{l}{**Implanted Ears with SNHL**} & \multicolumn{6}{c}{**Non-Implanted Ears with SNHL**} \\ \hline
**Ear \# (Patient \#)** & \begin{tabular}{l} **ECV** \\ **mL** \\ \end{tabular} & \begin{tabular}{l} **TPP** \\ **daPa** \\ \end{tabular} & \begin{tabular}{l} **SC** \\ **(mL)** \\ \end{tabular} & \begin{tabular}{l} **Type** \\ **(mL)** \\ \end{tabular} & \begin{tabular}{l} **Ear \# (Patient \#)** \\ \end{tabular} & \begin{tabular}{l} **ECV** \\ **mL** \\ \end{tabular} & \begin{tabular}{l} **TPP** \\ **daPa** \\ \end{tabular} & \
\begin{tabular}{l} **SC** \\ **(mL)** \\ \end{tabular} &
\begin{tabular}{l} **Type** \\ **Type** \\ \end{tabular} \\ \hline
10 (9) & 1.09 & \(-9\) & 1.29 & A & 10 (11) & 0.76 & 8 & 0.61 & A \\ \hline
11 (10) & 0.92 & \(-47\) & 0.37 & A & 11 (12) & 0.93 & \(-45\) & 0.64 & A \\ \hline
12 (11) & 0.84 & 4 & 0.38 & A & 12 (13) & 1.32 & 10 & 1.26 & A \\ \hline
13 (12) & 0.88 & \(-25\) & 0.26 & A & 13 (15) & 1.28 & \(-13\) & 0.87 & A \\ \hline
14 (13) & 1.05 & \(-35\) & 0.74 & A & 14 (16) & 0.6 & \(-4\) & 0.39 & A \\ \hline
15 (14) & 0.49 & 6 & 0.26 & A & 15 (17) & 1.37 & 2 & 0.39 & A \\ \hline
16 (14) & 0.59 & \(-16\) & 0.4 & A & & & & & \\ \hline
17 (15) & 0.85 & 3 & 0.65 & A & & & & & \\ \hline
18 (16) & 0.67 & 0 & 0.36 & A & & & & & \\ \hline
19 (17) & 1.17 & 0 & 0.47 & A & & & & & \\ \hline \end{tabular}
\end{table} 
Table 2: _Cont._  
Figure 4: Absorbance per frequency for the ambient and pressure setting for the three study conditions: normal-hearing ears (n = 48); non-implanted ears of only the unilaterally implanted CI participants (n = 15); and implanted ears, including two bilaterally implanted CI participants (n = 17).